Skip to content

Study of oligospermia patients with unani medicine majun e piyaz to increase sperm count

A single blind randomized controlled clinical trial to evaluate the safety and efficacy of majun piyaz in cases of qillate mani (oligosperma) - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/10/075266
Enrollment
40
Registered
2024-10-15
Start date
Unknown
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N461- Oligospermia

Interventions

Intervention1: Majun e piyaz: 12 gm. in morning with cow milk for 60 days Control Intervention1: Clomiphene Citrate: 25 mg daily OD after meal given for 24 days in a month with 6 days gap for 60 days

Sponsors

Government Nizamia Tibbi College and General hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age between 25-55 years. All socio-economical classes. No past history of renal, hepatic or any other chronic illness. History of unprotective intercourse for period of 12 months Infertile oligopsermia patient without any delayed puberty Infertile patient having oligospermia less than 15 million/ml of semen. Patients who willing for semen examination after the treatment.

Exclusion criteria

Exclusion criteria: Patient with complete Azoospermia in pre-samples. Evidence of male accessory gland infection like orchitis, mumps, varicocele and trauma to testis, excessive radiation to the testis and uncorrected bilateral cryptorchidism. Taking anti TB drugs, alpha blockers, spironolactone and any cytotoxic drugs. Patients suffering with anti-immune diseases like STD, HIV. Patient with diabetes mellitus,cardiac and thyroid diseases. Hormone treatment for promoting fertilty in the last three months,psychologically or mentally ill patients.

Design outcomes

Primary

MeasureTime frame
Increase in sperm countTimepoint: Day 0,day 30,day 60

Secondary

MeasureTime frame
Increase in male fertilityTimepoint: Day 0, day 30, day 60

Countries

India

Contacts

Public ContactDr Shaik Saifur Rehman

Government Nizamia Tibbi College and General Hospital

dr.faroqui@gmail.com9849139356

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026